Series B - Spruce Biosciences - 2020-02-20 - Crunchbase

Feb 20, 2020 · Spruce Biosciences raised $88000000 on 2020-02-20 in Series B. Omega Funds Omega Funds global life sciences-based investment firm that specializes in direct secondary …

CouponFollow Extension

$88000000
OFF

Series B - Spruce Biosciences - 2020-02-20 - Crunchbase

6 days from now

Feb 20, 2020 · Spruce Biosciences raised $88000000 on 2020-02-20 in Series B. Omega Funds Omega Funds global life sciences-based investment firm that specializes in direct secondary …

crunchbase.com

$88
OFF

Spruce Biosciences Raises $88 Million In Series B Financing, Co-led …

6 days from now

San Francisco, California — February 19, 2020 – Spruce Biosciences today announced it has raised $88 million in Series B financing co-led by Omega Funds and Abingworth and …

sprucebio.com

$9
OFF

Spruce Biosciences Reports First Quarter 2021 Financial Results …

6 days from now

Net Loss: Net loss for the three months ended March 31, 2021 was $9.9 million compared to $5.1 million for the same period in 2020. About Spruce Biosciences. Spruce Biosciences is a late …

sprucebio.com

$0.28
OFF

SPRB Spruce Biosciences, Inc. - Seeking Alpha

6 days from now

Spruce Biosciences GAAP EPS of -$0.28 beats by $0.02, revenue of $2M beats by $0.84M SA News Mon, May 13 Spruce Biosciences, Inc. SEC Filing - Quarterly Report (10-Q) May 13, 2024

seekingalpha.com

$100
OFF

These Are The Industries Where Series B Funding Is Growing Fastest

6 days from now

Nov 29, 2021 · Per Crunchbase data, there were 56 health care companies that raised Series B rounds of $100 million or more this year—a striking number considering that these are still …

crunchbase.com

$70
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

6 days from now

Apr 28, 2023 · Founded in 2020, the company has raised more than $70 million, per Crunchbase. 9. Antiva Biosciences, $53M, biotech: South San Francisco-based Antiva Biosciences — a …

crunchbase.com

$29000000
OFF

Series B - Spruce Holdings - 2020-05-21 - Crunchbase

6 days from now

May 21, 2020 · Spruce Holdings raised $29000000 on 2020-05-21 in Series B. Scale Venture Partners Scale is a seed-stage venture capital firm focused on intelligent business software.

crunchbase.com

$8
OFF

Spruce Biosciences Reports Fourth Quarter And Full Year 2021 …

6 days from now

Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates. ... compared to $8.3 million and $29.5 million for the same periods in …

sprucebio.com

$26000000
OFF

Series B - Spruce - 2022-07-19 - Crunchbase Funding Round Profile

6 days from now

Jul 19, 2022 · Spruce raised $26000000 on 2022-07-19 in Series B. Austin Inno — Apartment housekeeping startup Spruce gets new CEO, plus $26M from Sweat Equity Partners, …

crunchbase.com

$41
OFF

Series B - Parse Biosciences - 2022-02-15 - Crunchbase

6 days from now

Feb 15, 2022 · FinSMEs — Parse Biosciences Raises $41.5M in Series B Funding News • Feb 15, 2022 GeekWire — The ‘golden age’ for research tools: Parse Biosciences raises $41.5M …

crunchbase.com

$11513840
OFF

Series B - LISCure Biosciences - 2020-12-31 - Crunchbase

6 days from now

Dec 31, 2020 · LISCure Biosciences raised $11513840 on 2020-12-31 in Series B. Start Free Trial . Chrome Extension

crunchbase.com

FAQs about Series B - Spruce Biosciences - 2020-02-20 - Crunchbase Coupon?

How many investors does spruce biosciences have?

Spruce Biosciences has 12 investors including Abingworth and Rock Springs Capital. How much funding has Spruce Biosciences raised to date? Spruce Biosciences has raised . When was the last funding round for Spruce Biosciences? Spruce Biosciences closed its last funding round on Feb 9, 2023 from a Post-IPO Equity round. ...

Who is spruce Biosciences?

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. View contacts for Spruce Biosciences to access new leads and connect with decision-makers. Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. ...

When did spruce Biosciences close?

Spruce Biosciences closed its last funding round on Feb 9, 2023 from a Post-IPO Equity round. Who are Spruce Biosciences 's competitors? Alternatives and possible competitors to Spruce Biosciences may include Aro Biotherapeutics , Interius BioTherapeutics , and Sirnaomics. ...

How far is spruce Biosciences stock from the 52-week low?

According to the current price, Spruce Biosciences is 142.87% away from the 52-week low. What was the 52-week high for Spruce Biosciences stock? The high in the last 52 weeks of Spruce Biosciences stock was 5.93. According to the current price, Spruce Biosciences is 9.91% away from the 52-week high. ...

Is spruce Biosciences stock a good buy?

Spruce Biosciences stock has received a consensus rating of buy. The average rating score is and is based on 24 buy ratings, 1 hold ratings, and 0 sell ratings. What was the 52-week low for Spruce Biosciences stock? The low in the last 52 weeks of Spruce Biosciences stock was 0.41. ...

What is the price target for spruce Biosciences?

The 25 analysts offering price forecasts for Spruce Biosciences have a median target of 7.56, with a high estimate of 10.00 and a low estimate of 2.00. The median estimate represents a 7.77 difference from the last price of 0.59. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. ...